Chemours Company
(CC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 12-2013 | 12-2012 | |
| Sales | 1,682,000 | 0 | 0 |
| Cost of Goods | 1,311,000 | N/A | N/A |
| Gross Profit | 371,000 | N/A | N/A |
| Operating Expenses | 243,000 | 0 | 0 |
| Operating Income | 128,000 | N/A | N/A |
| Other Income | 27,000 | 0 | 0 |
| Pre-tax Income | 155,000 | 0 | 0 |
| Income Tax | 39,000 | N/A | N/A |
| Net Income Continuous | 116,000 | N/A | N/A |
| Net Income | $116,000 | $N/A | $N/A |
| EBITDA(a) | $128,000 | $N/A | $N/A |